Results 151 to 160 of about 16,017 (247)
Oral biopharmaceutics tools - Time for a new initiative - An introduction to the IMI project OrBiTo
OrBiTo is a new European project within the IMI programme in the area of oral biopharmaceutics tools that includes world leading scientists from nine European universities, one regulatory agency, one non-profit research organization, four SMEs together ...
Verwei, M. +26 more
core
Interactions between lactobacillus and yeast: A recent update
Abstract Lactobacillus and yeast are microorganisms widely distributed in nature. Their interactions significantly impact fermentation processes, human health, and medical care. However, there is a lack of a systematic summary of the characteristics of these interactions, and the mechanisms underlying these interactions remain unclear.
Yang Chen +10 more
wiley +1 more source
Sex-Related Differences in Physiologically-Based Biopharmaceutics Modeling. [PDF]
Chavarría-Rojas M +4 more
europepmc +1 more source
Application of New Approach Methodologies to Improve Oral Biopharmaceutic Assessments. [PDF]
García MA +4 more
europepmc +1 more source
This review outlines specific peptide enrichment strategies, including metal, magnetic oxides, functional polymers, and antibody‐based approaches, and their mechanisms, highlighting applications in biomarker discovery for major neurological and psychiatric disorders.
Xue Zhang +8 more
wiley +1 more source
Accelerating Subcutaneous Drug Development: A Mechanistic Absorption Model for the Open Systems Pharmacology Framework. [PDF]
Pellowe M, Dubbelboer I, Sjögren E.
europepmc +1 more source
Abstract Since the early 1960s, nanotechnology has been a critical area of science, allowing for the development of sophisticated nanomaterials. Nanofibers, one of the most widely used nanotechnological drug delivery systems, have emerged as a highly versatile platform within modern pharmaceutical sciences.
Heybet Kerem Polat +7 more
wiley +1 more source
Re-entering the cell: Is the intracellular space the true therapeutic niche for aptamers? [PDF]
Giangrande PH.
europepmc +1 more source
ABSTRACT Cerebral ischemia–reperfusion injury (CI/RI) is a major cause of secondary neuronal damage following ischemic stroke. This study investigated whether terazosin (TZ) exerts neuroprotective effects by regulating mitophagy and the reactive oxygen species (ROS)/NOD‐like receptor protein 3 (NLRP3) inflammasome axis.
Wei Wang +5 more
wiley +1 more source

